ECSP993217A - NEW TREATMENT METHOD VII - Google Patents

NEW TREATMENT METHOD VII

Info

Publication number
ECSP993217A
ECSP993217A ECSP993217A ECSP993217A EC SP993217 A ECSP993217 A EC SP993217A EC SP993217 A ECSP993217 A EC SP993217A EC SP993217 A ECSP993217 A EC SP993217A
Authority
EC
Ecuador
Prior art keywords
treatment method
new treatment
diabetes mellitus
method vii
effective
Prior art date
Application number
Other languages
Spanish (es)
Inventor
Lisa Benincosa
William Jusko
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Priority to ECSP993217 priority Critical patent/ECSP993217A/en
Publication of ECSP993217A publication Critical patent/ECSP993217A/en

Links

Landscapes

  • Investigating Or Analysing Biological Materials (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)

Abstract

Un método para el tratamiento de diabetes mellitus de tipo 2 y condiciones asociadas con diabetes mellitus, cuyo método comprende la administración de una cantidad eficaz y no tóxica de un sensibilizador de insulina a un mamífero humano o no humano con necesidad de ello, con objeto de proporcionar una concentración plásmática umbral dentro del intervalo de niveles plasmáticos eficaces del sesibilizador de insulina, composiciones para el uso de dicho método y metodologia para determinar concentraciones plasmáticas de agente activo para uso en tales métodos.A method for the treatment of type 2 diabetes mellitus and conditions associated with diabetes mellitus, which method comprises administering an effective and non-toxic amount of an insulin sensitizer to a human or non-human mammal in need thereof, in order to to provide a threshold plasma concentration within the range of effective plasma levels of the insulin sesibilizer, compositions for use of said method, and methodology for determining plasma concentrations of active agent for use in such methods.

ECSP993217 1999-11-12 1999-11-12 NEW TREATMENT METHOD VII ECSP993217A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
ECSP993217 ECSP993217A (en) 1999-11-12 1999-11-12 NEW TREATMENT METHOD VII

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ECSP993217 ECSP993217A (en) 1999-11-12 1999-11-12 NEW TREATMENT METHOD VII

Publications (1)

Publication Number Publication Date
ECSP993217A true ECSP993217A (en) 2000-03-22

Family

ID=42044205

Family Applications (1)

Application Number Title Priority Date Filing Date
ECSP993217 ECSP993217A (en) 1999-11-12 1999-11-12 NEW TREATMENT METHOD VII

Country Status (1)

Country Link
EC (1) ECSP993217A (en)

Similar Documents

Publication Publication Date Title
PE20071310A1 (en) LIQUID PHENYLEPHRINE FORMULATIONS
MX337422B (en) COMPOSITIONS AND METHODS TO INCREASE INSULIN SENSITIVITY.
PE20090966A1 (en) COMBINATION THERAPY OF A TYPE II ANTI-CD20 ANTIBODY WITH AN ANTI-BCL-2 ACTIVE AGENT
AR061772A1 (en) COMPOSITION OF HIGH CONTENT OF ION FLUORIDE FOR ORAL CARE AND METHOD TO MAINTAIN ANTICARIES ACTIVITY
AR038575A1 (en) OPHTHALM FORMULATION WITH NEW RUBBER COMPOSITION
ECSP088239A (en) COMPOSITION OF SUSTAINED DRUG RELEASE
CY1107649T1 (en) A COMBINATION CONTAINING AN ANTIFOLIC SALT AND Methylphenolic Acid Reduction Factors
CO5261563A1 (en) PHARMACEUTICAL COMPOSITIONS THAT PROVIDE POWERFUL FARMACO CONCENTRATIONS
AR033059A1 (en) INSULIN PREPARED EXEMPT FROM ZINC AND POOR IN ZINC, WITH IMPROVED STABILITY.
NZ566083A (en) Methods and compositions for prevention and treatment of diabetic and aged skin
EA201200475A1 (en) HIGHLY CONCENTRATED PHARMACEUTICAL COMPOSITIONS CONTAINING ANTIBODY TO CD20
MA30768B1 (en) METHODS OF ADMINISTERING HYPOGLYCEMIC AGENTS WITH LONG TERM OF ACTION
SV2002000969A (en) RECONSTITUABLE PARENTERAL COMPOSITION
ATE348630T1 (en) REDUCING SIDE EFFECTS OF CHEMOTHERAPY IN CANCER PATIENTS
EA200200502A1 (en) METHOD OF INTRODUCTION OF PHOSPHODYSTRASE 4 INHIBITOR
UY25797A1 (en) METHOD FOR THE TREATMENT OF DIABETES MELLITUS TYPE 2
ECSP993217A (en) NEW TREATMENT METHOD VII
AR042598A1 (en) ACETAMINOPHENE COMPOSITIONS
MX2007009312A (en) Injectable preparations of diclofenic and its pharmaceutically acceptable salts.
ES2044534T3 (en) A METHOD FOR THE PREPARATION OF A THROMBOLITICALLY ACTIVE COMPOSITION.
CO5690605A2 (en) CCI-779 TO TREAT HAND CELL LYMPHOMA
BRPI0415576A (en) personal care composition containing a detersive surfactant, an anti-dandruff component and ketoamide surfactants
ECSP982591A (en) NEW METHOD OF TREATMENT IV
ECSP982535A (en) NEW TREATMENT METHOD (I)
ECSP982592A (en) NEW METHOD OF TREATMENT V